Latest Updates

Conference

SphynxVision™ makes its debut at WMIC 2026

What an exciting few days in Salt Lake City as we officially introduced SphynxVision™ to the molecular imaging community at WMIC 2026.

For our team, this was much more than exhibiting a new imaging device. It was an opportunity to introduce SphynxVision to researchers, demonstrate the technology in person, and hear how scientists envision using an open-field fluorescence imaging platform in their own research. These conversations also opened exciting possibilities for new avenues of research that could benefit from SphynxVision.

SphynxVision enables high-resolution, real-time preclinical fluorescence imaging in ambient light while maintaining continuous access to the animal. At WMIC, this led to fascinating conversations around dynamic imaging, image-guided procedures, drug delivery, tumor imaging, vascular imaging, and other applications where portability, open bench space, high resolution, and continuous access for intervention can make a real difference.

We were especially encouraged by the curiosity and engagement at our booth. Researchers did not just want to see images; they wanted to understand how the system worked, interact with it, and explore what they could do differently with an open imaging platform that provided high-resolution imaging in an ambient light setting.

And SphynxVision was not only on the exhibition floor. Four studies presented at WMIC 2026 used the SphynxVision platform across different preclinical imaging applications and a clinical application with human biopsy samples, providing an exciting glimpse into the range of science that can be performed with the system.

A huge thank you to everyone who visited us, shared their research challenges, asked tough questions, and gave us ideas about where this technology could go next.

We came to WMIC 2026 to introduce SphynxVision and left with new ideas, new relationships, new collaborations, and a growing community of researchers and friends. We are even more excited about what comes next.

SphynxVision. Imaging Brilliance. Outside the Box.

Company News

SphynxVision™ in the spotlight

This week, we publicly announced SphynxVision™ to the outside world. SphynxVision is our portable, open-field fluorescence imaging platform designed to help researchers perform high-resolution, real-time preclinical fluorescence imaging in an ambient light setting, including directly on the lab bench.

Following our press release on GlobeNewswire, we were excited to see SphynxVision featured by MUSC Hollings Cancer Center in a story exploring the scientific need that inspired the technology and its journey from the research lab toward commercialization. The news was also syndicated by Yahoo Finance and appeared on EurekAlert.

SphynxVision reinvents preclinical fluorescence imaging by enabling high-resolution, real-time imaging under ambient lighting while maintaining continuous access to the animal during imaging, surgery, drug administration, and other interventions.

Read the stories:
GlobeNewswire: OncoBLAZE introduces SphynxVision
EurekAlert coverage

And next week, we are excited to see all of you at WMIC 2026 in Salt Lake City, September 8-11. Visit us at Booth #403.

Conference

SphynxVision High-Resolution Dynamic Imaging abstract accepted for WMIC 2026

An abstract was accepted at the World Molecular Imaging Conference (WMIC) 2026, describing dynamic contrast-enhanced fluorescence imaging of mouse tumors using an open imaging system. The work shows that high frame rate fluorescence imaging can identify arterial and venous phases, generate tumor angiograms, and produce pharmacokinetic maps with substantially higher spatial resolution than DCE-MRI.

Conference

Preclinical Fluorescence Image-guided Surgery (IGS) abstract accepted for WMIC 2026

An abstract was accepted at the World Molecular Imaging Conference (WMIC) 2026, highlighting open-system GFP fluorescence imaging for image-guided procedures in mice. The study reports short exposure times, reduced motion artifacts, clear tumor-to-background contrast, and visualization of small tumor fragments and capillaries during surgery.

Conference

SphynxVision intra-procedural imaging work to be presented at IEEE EMBC 2026

This research describes how SphynxVision supports image-guided surgery under normal lighting, without moving the animal into a dark chamber. In a GFP-labeled mouse tumor model, the system enabled intermittent intra-procedural imaging in the surgical field, achieved strong tumor-to-background contrast, and captured high-resolution images of extracted tumor fragments using a macro lens.

Conference

Fluorescence imaging by SphynxVision tracks chemotherapy delivery from thermosensitive liposomes

Presented at the 2026 Society for Thermal Medicine conference, this research describes the use of fluorescence imaging to visualize chemotherapy delivery from thermosensitive liposomes. The work highlights how open fluorescence imaging can track heat-triggered drug release and delivery dynamics in real time, supporting studies in which thermal therapy, dosing, and imaging need to occur together during the experiment.

Conference

Real-time chemotherapy delivery visualization presented at WMIC 2025

Presented at the World Molecular Imaging Congress (WMIC) 2025 in Anchorage, AK, the research described a fluorescence imaging system for real-time visualization of chemotherapy delivery. The work highlights how open-access fluorescence imaging can help researchers observe drug delivery as it happens, map spatial delivery patterns, and assess dynamic treatment response beyond endpoint measurements.